当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 现金流量表

金城医药

(300233)

  

流通市值:53.25亿  总市值:55.28亿
流通股本:3.70亿   总股本:3.84亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金585,641,780.022,345,797,951.181,708,973,946.321,179,279,499.63
  收到的税费返还936,341.9510,226,971.337,687,320.756,006,474.87
  收到其他与经营活动有关的现金7,615,216.7166,431,337.3154,969,876.9937,819,783.07
  经营活动现金流入小计594,193,338.682,422,456,259.821,771,631,144.061,223,105,757.57
  购买商品、接受劳务支付的现金200,902,843.86860,701,758.11650,602,007.59457,323,403.98
  支付给职工以及为职工支付的现金174,769,301.62591,082,789.77463,882,077.55339,477,303.84
  支付的各项税费54,098,500.94205,870,894.6143,315,303.14110,080,470.77
  支付其他与经营活动有关的现金76,920,695.12445,160,776.08329,649,494.21211,856,667.41
  经营活动现金流出小计506,691,341.542,102,816,218.561,587,448,882.491,118,737,846
  经营活动产生的现金流量净额87,501,997.14319,640,041.26184,182,261.57104,367,911.57
二、投资活动产生的现金流量:
  取得投资收益收到的现金-1,200,000--
  处置固定资产、无形资产和其他长期资产收回的现金净额35,276,75023,788,023.27,744,123.27,648,287.2
  收到的其他与投资活动有关的现金563,175,953.611,456,950,656.53742,175,481.7490,799,553.67
  投资活动现金流入小计598,452,703.611,481,938,679.73749,919,604.9498,447,840.87
  购建固定资产、无形资产和其他长期资产支付的现金28,113,567.01100,883,345.2974,302,639.6235,469,377.05
  支付其他与投资活动有关的现金662,100,0001,537,011,200813,000,000490,000,000
  投资活动现金流出小计690,213,567.011,637,894,545.29887,302,639.62525,469,377.05
  投资活动产生的现金流量净额-91,760,863.4-155,955,865.56-137,383,034.72-27,021,536.18
三、筹资活动产生的现金流量:
  取得借款收到的现金60,000,000137,975,000137,975,000126,975,000
  筹资活动现金流入小计60,000,000137,975,000137,975,000126,975,000
  偿还债务支付的现金102,500,000272,030,193.26271,245,193.26269,245,193.26
  分配股利、利润或偿付利息支付的现金1,962,169.53162,507,415.06160,296,069.32120,109,129.55
  支付其他与筹资活动有关的现金589,0002,136,464.961,425,2421,161,908
  筹资活动现金流出小计105,051,169.53436,674,073.28432,966,504.58390,516,230.81
  筹资活动产生的现金流量净额-45,051,169.53-298,699,073.28-294,991,504.58-263,541,230.81
四、汇率变动对现金及现金等价物的影响-860,202.481,843,586.641,973,205.381,867,868.36
五、现金及现金等价物净增加额-50,170,238.27-133,171,310.94-246,219,072.35-184,326,987.06
  加:期初现金及现金等价物余额745,312,799.46878,484,110.4878,484,110.4878,484,110.4
  期末现金及现金等价物余额695,142,561.19745,312,799.46632,265,038.05694,157,123.34
补充资料:
  净利润-42,273,760.23-44,966,077.75
  资产减值准备-55,662,378.95-8,134,729.93
  固定资产和投资性房地产折旧-249,234,152.58-123,515,309.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-249,234,152.58-123,515,309.38
  无形资产摊销-69,760,607.52-32,791,304.13
  长期待摊费用摊销-3,157,542.65-1,613,648.67
  处置固定资产、无形资产和其他长期资产的损失--2,948,972.26--388,847.35
  固定资产报废损失-1,088,583.68--80,388.22
  公允价值变动损失-86,057.68-143,866.15
  财务费用-11,288,052.4-4,271,753.33
  投资损失--2,787,697.93--967,435.41
  递延所得税--2,622,659.53-78,681.93
  其中:递延所得税资产减少-16,335,959.18-11,188,046.9
    递延所得税负债增加--18,958,618.71--11,109,364.97
  存货的减少-101,367,946.3--15,060,506.46
  经营性应收项目的减少-58,167,638.44-106,942,546.84
  经营性应付项目的增加--263,480,657.47--194,049,412.22
  现金的期末余额-745,312,799.46-694,157,123.34
  减:现金的期初余额-878,484,110.4-878,484,110.4
  现金及现金等价物的净增加额--133,171,310.94--184,326,987.06
公告日期2026-04-242026-03-272025-10-272025-08-21
审计意见(境内)标准无保留意见
TOP↑